Cite

HARVARD Citation

    Spyrou, A. et al. (2017). Audit of the Impact on Chemotherapy Prescribing by Results of the EndoPredict Assay in Patients with N1 Breast Cancer. Clinical oncology. 29 (6), pp. e103-e104. [Online]. 
  
Back to record